News
The Food and Drug Administration is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, a move that would add another barrier for parents ...
A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency's top ...
The R21/Matrix-M malaria vaccine generates nearly identical antibodies as those following a natural infection, helping ...
Q2 2025 Earnings Call Transcript August 6, 2025 Novavax, Inc. beats earnings expectations. Reported EPS is $0.601, ...
The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results